M&A Deal Summary

Lumanity Acquires BresMed

On February 26, 2020, Lumanity acquired business services company BresMed

Acquisition Highlights
  • This is Lumanity’s 1st transaction in the Business Services sector.
  • This is Lumanity’s 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2020-02-26
Target BresMed
Sector Business Services
Buyer(s) Lumanity
Deal Type Merger
Advisor(s) Achelous Partners (Financial)
Keebles LLP (Legal)

Target

BresMed

Sheffield, United Kingdom
BresMed is a health economic and outcomes research consultancy that provides health economic solutions to the global pharmaceutical industry. BresMed’s services span the full product development pipeline, allowing it to support its clients from initial portfolio planning, strategy development, and health technology assessment through to post-launch value demonstrations in multiple jurisdictions. BresMed was founded in 2006 and is based in Sheffield, United Kingdom.

Search 215,130 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Lumanity

Bethesda, Maryland, United States

Category Company
Founded 2020
Sector Business Services
DESCRIPTION

Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. With deep experience in medical, commercial, and regulatory affairs, the company transforms data and information into real-world insights and evidence that powers successful commercialization and empowers patients, providers, payers, and regulators to take timely and decisive action. Lumanity was formed in 2020 and is based in Bethesda, Maryland.


DEAL STATS #
Overall 1 of 8
Sector: Business Services M&A 1 of 4
Type: Merger M&A Deals 1 of 2
Country: United Kingdom M&A 1 of 3
Year: 2020 M&A 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-08-11 Cello Health

London, United Kingdom

Cello Health is a global healthcare-focused advisory firm comprised of a set of leading scientific, commercial advisory, and digital delivery capabilities. Cello Health currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices, and other key non-healthcare clients. Cello Health is based in London, United Kingdom.

Buy £182M